Egor Demin set an NBA rookie record by making a 3-pointer in his 34th straight game and finished with 25 points and 10 rebounds to help the Brooklyn Nets snap a seven-game losing streak with a 109-99 ...

Put rules at the capability boundary: Use policy engines, identity systems, and tool permissions to determine what the agent ...

A critical vm2 Node.js vulnerability (CVE-2026-22709, CVSS 9.8) allows sandbox escape via Promise handler bypass.

A critical-severity vulnerability in the vm2 Node.js sandbox library, tracked as CVE-2026-22709, allows escaping the sandbox and executing arbitrary code on the underlying host system.

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...

Chrome, Edge, and Firefox are full of bloatware, with AI among the features most of us don't want. This free tool is your ticket back to the good old days.

The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in more than 55 early-stage AI companies, in partnership with Inovia Capital ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Wondering if Recursion ...

Node.js released updates fixing a critical DoS flaw caused by async_hooks stack crashes, tracked as CVE-2025-59466, impacting most production apps.

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...